Chromatic VRE, ComASP Oritavancin

Liofilchem^®

Microbiology products

Solutions for Antimicrobial Resistance Management

Chromatic VRE

Chromogenic medium for screening vancomycin-resistant enterococci.

Chromatic VRE contains a mixture of antibiotics including vancomycin for screening Vancomycin-resistant enterococci (VRE) and provides presumptive identification of Enterococcus faecium and Enterococcus faecalis directly from clinical specimens.

VRE have recently been recognized as one of the most severe cause of nosocomial infections.

An intrinsic resistance (vanC, vanD, vanE, vanF etc) is found in E. gallinarum and E. casseliflavus/E. flavescens and shows low resistance to vancomycin. Instead, an acquired resistance of vancomycin in enterococci (vanA & vanB types) is mostly detected in E. faecium and E. faecalis.

The prompt detection of Vancomycin-resistance of E. faecium and E. faecalis is basic for avoiding the spread of this resistance to more virulent such as S. aureus.

Download the product IFU

20 plates/pack

Catalog ref. 11621

2-8°C storage temperature

3 months shelf life

Learn more about our chromogenic culture media for detecting antimicrobial resistance mechanisms

ComASP^® Oritavancin

Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive pathogens, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), streptococci and enterococci.

ComASP® (Compact Antimicrobial Susceptibility Panel) Oritavancin is a 2-test panel containing the dried up antibiotic in 15 two-fold dilutions (0.001-16 μg/ml).

Ref. 75010

2 tests/panel

4 panels/pack

Click here to download the Instructions For Use.

ComASP® Oritavancin is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO 20776-1:2006).

Choose among one of the following nine preset panels or request customized 32-well panel formats with over 100 antibiotics available: